Salarius Pharmaceuticals to Deliver Virtual Presentation at the Emerging Growth Invitational
22 avr. 2020 08h00 HE
|
Salarius Pharmaceuticals, Inc.
HOUSTON, April 22, 2020 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting cancers caused by dysregulated gene expression, announced today...
Salarius Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results
23 mars 2020 16h18 HE
|
Salarius Pharmaceuticals, Inc.
Seclidemstat Achieves Dose-Escalation Milestone in Phase 1/2 Ewing Sarcoma Clinical Trial Sixth Level Dosing Cohort Now Proceeding; On Track To Report Topline Data in 2020 HOUSTON, March 23,...